Search
Categories


Archive for September, 2006

Newsdesk: First-Trimester Exposure to Lamictal May Cause Oral Cleft

Saturday, September 30th, 2006

Author: NewsEditor
Subject: First-Trimester Exposure to Lamictal May Cause Oral Cleft
Posted: Sat 30 Sep 2006 1:05 pm (GMT 1) Preliminary registry data suggest a link between lamotrigine and oral cleft.<br><i>Medscape Medical News</i><br>Yael Waknine …view forum post_________________News Editor, CounsellingResource.com Also see our Daily Mental Health News Page (Source: CounsellingResource.com News and Features)

U.S. says Glaxo drug may be linked to birth defect

Friday, September 29th, 2006

WASHINGTON (Reuters) – Taking GlaxoSmithKline Plc’s Lamictal epilepsy drug during the first three months of pregnancy may increase the chances of having a baby with a cleft lip or palate, U.S. regulators warned on Friday. (Source: Reuters: Health)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Effect of Different Terpene-Containing Essential Oils on Percutaneous Absorption of Trazodone Hydrochloride Through Mouse Epidermis

Friday, September 29th, 2006

(Source: Drug Delivery)

FDA warns about epilepsy drug, birth defect

Friday, September 29th, 2006

WASHINGTON (Reuters) – Taking GlaxoSmithKline Plc’s Lamictal epilepsy drug during the first three months of pregnancy may increase the chances of having a baby with a cleft lip or palate, U.S. regulators warned on Friday. (Source: Reuters: Health)

FDA Approvals: Verdeso and Lamictal

Friday, September 29th, 2006

The FDA has approved desonide 0.05% foam (Verdeso) and a new indication for lamotrigine tablets (Lamictal). (CME,CE)Medscape Medical News (Source: Medscape PublicHealth Headlines)

FDA OKs GSK drug to combat grand mal seizures

Thursday, September 28th, 2006

The U.S. Food and Drug Administration again has extended its marketing approval for GlaxoSmithKline’s epilepsy treatment Lamictal. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

FDA Approves New Epilepsy Indication For Lamictal(R)

Wednesday, September 27th, 2006

The Food and Drug Administration today approved a new use of the anti-seizure medicine Lamictal(R) (lamotrigine) Tablets for the treatment of one of the most serious forms of epilepsy — Primary Generalized Tonic-Clonic (PGTC) seizures, also known as “grand mal” seizures. With this new indication, Lamictal can now be used as add-on therapy to treat PGTC seizures in children aged 2 and older as well as adults. [click link for full article] (Source: Epilepsy News From Medical News Today)

FDA Approves New Epilepsy Indication For Lamictal®

Wednesday, September 27th, 2006

The Food and Drug Administration today approved a new use of the anti-seizure medicine Lamictal® (lamotrigine) Tablets for the treatment of one of the most serious forms of epilepsy — Primary Generalized Tonic-Clonic (PGTC) seizures, also known as “grand mal” seizures. With this new indication, Lamictal can now be used as add-on therapy to treat PGTC seizures in children aged 2 and older as well as adults. [click link for full article] (Source: Epilepsy News From Medical News Today)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

FDA approves new epilepsy indication for Lamictal®

Tuesday, September 26th, 2006

The Food and Drug Administration today approved a new use of the anti-seizure medicine Lamictal® (lamotrigine) Tablets for the treatment of one of the most serious forms of epilepsy — Primary Generalized Tonic-Clonic (PGTC) seizures, also known as “grand mal” seizures. With this new indication, Lamictal can now be used as add-on therapy to treat PGTC seizures in children aged two and older as well as adults. (Source: EurekAlert! – Biology)

FDA Approves New Epilepsy Indication For Lamictal(R)

Tuesday, September 26th, 2006

The Food and Drug Administration today approved a new use of the anti-seizure medicine Lamictal(R) (lamotrigine) Tablets for the treatment of one of the most serious forms of epilepsy — Primary Generalized Tonic-Clonic (PGTC) seizures, also known as “grand mal” seizures. With this new indication, Lamictal can now be used as add-on therapy to treat PGTC seizures in children aged 2 and older as well as adults. [click link for full article] (Source: Bipolar News From Medical News Today)

Page 1 of 41234